Results 91 to 100 of about 77,168 (308)

Effect of Statin Intensity on Cardiovascular Outcomes and Survival Following Coronary Artery Bypass Grafting. [PDF]

Clin Cardiol
ABSTRACT Background High‐intensity statins are recommended for patients with chronic coronary artery disease, with reports suggesting improved clinical outcomes. However, recent findings in coronary artery bypass graft (CABG) patients question whether a treat‐to‐target low density lipoprotein (LDL) approach is non‐inferior to high‐intensity statin ...
Ch IA, Nasir K, Majeed U, Chaudhry A, Abdullah M, Haider A, Jamal A, Hussain A, Iftikhar H, Khalid S, Wu PT, Shah Y, Niaz A, Siddique M, Tahirkheli N.   +14 more
europepmc   +2 more sources

Postoperative Evaluation of Myocardial Blood Flow in Aorta-to-Coronary Artery Vein Bypass Grafts Using the Xenon-Residue Detection Technic [PDF]

, 1972
P Lichtlen, T Moccetti, Jeffrey B. Halter, M Schönbeck, A Senning   +4 more
openalex   +1 more source

Prognostic value of left atrial strain in acute and chronic heart failure: A meta‐analysis

ESC Heart Failure, EarlyView.
The prognostic evaluation of heart failure (HF) beyond ejection fraction remains challenging. Moreover, reliable prognosticators in chronic HF sometimes lose their value in acute settings or vice versa. Speckle tracking echocardiography offers new sensitive parameters for prognostic stratification in heart failure with reduced and preserved ejection ...
Maria Concetta Pastore, Mariangela Vigna, Andrea Saglietto, Maria Alma Iuliano, Giulia Elena Mandoli, Andrea Stefanini, Chiara Carrucola, Laura Fusini, Luna Cavigli, Flavio D'ascenzi, Marta Focardi, Serafina Valente, Matteo Cameli   +12 more
wiley   +1 more source

Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization

Vascular Health and Risk Management, 2011
Grigorios Tsigkas, Panagiota Mylona, Periklis Davlouros, Dimitrios AlexopoulosCardiology Department, University Hospital of Patras, Patras, GreeceAbstract: Despite the remarkable advances in revascularization strategies made during the last decade, a ...
Tsigkas G, Mylona P, Davlouros P, Alexopoulos D   +3 more
doaj  

Impact of mitral valve transcatheter edge‐to‐edge repair on haemodynamic parameters in cardiogenic shock

ESC Heart Failure, EarlyView.
Abstract Background Transcatheter edge‐to‐edge repair (TEER) has been shown to be an effective treatment option for patients experiencing cardiogenic shock (CS) with concomitant high‐grade mitral valve regurgitation. However, haemodynamic changes following M‐TEER have not been thoroughly investigated. Afterload mismatch, leading to the deterioration of
Michal Droppa, Dominik Rath, Philippa Jaeger, Ioannis Toskas, Monika Zdanyte, Andreas Goldschmied, Jürgen Schreieck, Meinrad Gawaz, Tobias Geisler   +8 more
wiley   +1 more source

Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

ESC Heart Failure, EarlyView.
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, on behalf of the Altshock‐2 investigators   +21 more
wiley   +1 more source

Closure of postinfarction ventricular septal defect, left ventricular aneurysmectomy, and coronary artery bypass graft: Case report [PDF]

, 1973
Zev Davis, J.B. Borman, U Freund, S Stern   +3 more
openalex   +1 more source

Short report: Hospitalization for new‐onset heart failure in survivors of hospitalized COVID‐19

ESC Heart Failure, EarlyView.
Abstract Aims Previous studies have reported an incidence of new‐onset heart failure (HF) among COVID‐19 survivors ranging from 0.7 to 8.5 per 100 person‐years, but they relied on administrative data for outcome ascertainment. Given the public health implications, a more accurate characterization of the HF burden post‐COVID‐19 is important. Methods and
Vicente Corrales‐Medina, Jordana B. Cohen, Seavmeiyin Kun, Bianca Pourmussa, Ozgun Erten, Joe‐David Azzo, Julio A. Chirinos   +6 more
wiley   +1 more source

The effect of treatment timing on repeat revascularization in patients with stable ischemic heart diseaseCentral MessagePerspective

JTCVS Open
Objectives: In patients with stable ischemic heart disease, there is no evidence for the effect of revascularization treatment timing on the need for repeat procedures.
Sean Hardiman, PhD, MHA, Guy Fradet, MD, MSc, Lisa Kuramoto, MSc, Michael Law, PhD, Simon Robinson, MB, ChB, MD, Boris Sobolev, PhD   +5 more
doaj  

Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support

ESC Heart Failure, EarlyView.
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau, Laura Coyle, Rachel Pedersen, Colleen Gallagher, Nicole Graney, Lisa Kukla, Robin Paliga, Gregory P. Macaluso, Sunil Pauwaa, William G. Cotts, Patroklos S. Pappas, Antone J. Tatooles, Nikhil Narang   +12 more
wiley   +1 more source